Short description
Veru is a biopharmaceutical company that specializes in developing novel medicines.
Description
Veru is a biopharmaceutical company that focuses on infectious diseases and oncology. They develop novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers. Their development portfolio includes sabizabulin, enobosarm, zuclomiphene citrate, and more.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Miami, Florida, United States, North America
Founded on
January 1, 2016
Exited on
July 20, 1990
Went public on
July 20, 1990
Stock symbol
VERU
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Founders
Harry Fisch, Mitchell Steiner